Acta paediatrica (Oslo, Norway : 1992) · 2004
Antipsychotic medication and marked hyperprolactinaemia: iatros or true prolactinoma?
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Koves I H, Jarman F C, Cameron F J
Аннотация
AIM: To demonstrate that hyperprolactinaemia and/or prolactinoma occur in association with antipsychotic medication use.
METHODS: Three case studies of patients with markedly elevated serum prolactin level (>132 microg/l); either antipsychotic medication induced or as a consequence of a prolactinoma.
CONCLUSION: The management and investigation of children with markedly elevated serum prolactin levels remains poorly defined. In our case series, two patients were found to have prolactinomas. We suggest that paediatric patients with serum prolactin level above 50 microg/l in males and 70 microg/l in females, regardless of any antipsychotic medication use, receive magnetic resonance imaging to exclude prolactinoma.
METHODS: Three case studies of patients with markedly elevated serum prolactin level (>132 microg/l); either antipsychotic medication induced or as a consequence of a prolactinoma.
CONCLUSION: The management and investigation of children with markedly elevated serum prolactin levels remains poorly defined. In our case series, two patients were found to have prolactinomas. We suggest that paediatric patients with serum prolactin level above 50 microg/l in males and 70 microg/l in females, regardless of any antipsychotic medication use, receive magnetic resonance imaging to exclude prolactinoma.